Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
Revolution Medicines, Inc.
UNICANCER
The Center for Clinical and Cosmetic Research
Advaxis, Inc.
Umeå University
Revolution Medicines, Inc.
Fate Therapeutics
Institut de Cancérologie de Lorraine
University Health Network, Toronto
Ontario Clinical Oncology Group (OCOG)
University of California, San Diego
The University of Texas Medical Branch, Galveston
Memorial Sloan Kettering Cancer Center
Emory University
Memorial Sloan Kettering Cancer Center
Tufts Medical Center